Ann: Cynata completes $5.0m Placement and launches SPP, page-4

I think @Pledge  was right  - Ross seems to have no idea how much an FDA USA clinical trials cost if he thinks that this dismal CR of $7 million less costs ($5m = $2m SPP) will keep the lights on and pay for the GVHD trial in the USA ....


..... but wait the 'options' some will say will cover the shortfall through to 2025 - assuming they are even exercised and everything else goes to plan ? 30 cents you say Ross ... Hmmm what happens to the share price if either the DFU trial or the OA trial fail ?


IMO it doesn't look like many were interested if $5 million was all the Sophs contributed or the unnamed "Specialist Healthcare Fund" ?  If Fuji didn't contribute, then we are likely to see a "Ceasing to be a Substantial Holder Notice" as they will drop below 5% threshold